The BioPortUSA Advisory Board provides high level intellectual and strategic guidance to the core team. Its members are leaders in their fields and bring valuable industry insight for BioPortUSA management.
Dr. Eric Beier is the CEO of Matrix-Bio, a cancer diagnostics company developing metabolomics-based diagnostic tests for early detection of liver cancer, colon cancer and ovarian cancer. He is also the President of the Fort Wayne Chapter of VisonTech Angels and the Founder and Managing Member of Maple Seed Capital. Prior positions include Chief Medical Officer of MediGain, a global physician revenue cycle management company. He was the Founder and President of MedOptima, a physician revenue cycle management, practice management and consulting company which was purchased by MediGain. He also started up several physician practices and an emergency medicine billing company. Dr. Beier was the Productline Manager for Cardiovascular Diagnostics at Boehringer Mannheim Corporation (now part of Roche Diagnostics) and practiced as an emergency physician in Indiana. He has served as a board member and leader for several nonprofits including the Indiana Chapter of the American College of Emergency Physicians, the Fort Wayne Medical Society, the Northeast Indiana Innovation Center, and Crossroad Child and Family Services.
Dr. Beier graduated summa cum laude from Hanover College with a Bachelor's of Arts in Chemistry. He earned his medical degree from the Indiana University School of Medicine and an MBA from the University of Michigan.
David is an enterprise leader focused on the convergence of technology development, innovation process, strategic alliances and market adoption. His executive responsibilities cover corporate strategy, venture funding, technology transfer agreements and mergers and acquisitions totaling over $1 Billion.
Beginning his career in 1995 in Marketing & Advertising at Eric Mower & Associates, David led the agency team that launched the first video endoscope for Welch Allyn Medical, targeting Primary Care and Specialty Physicians to incentivize training and adoption of a new cancer diagnostic device. In 1998, as VP Of Marketing for B.G. Sulzle, he was responsible for diversifying revenue mix with Top 20 global customers by negotiating annual supply agreements and technology licensing, accelerating the growth of the family-owned and operated B2B medical device manufacturer.
David has held VP-level positions for InterV Medical Group, Angiotech Pharmaceuticals and Blue Highway, where he has been responsible for product development, revenue growth, new venture creation, opportunity assessment and research & development.
From 2013 to 2016, David served as Director Of Strategic Development for AARP/Life Reimagined Institute for Innovation, focused on improving health and wellness of 50 Million Americans through a continuum of digital and live event experiences. His responsibilities included strategic growth & innovation, new market success, new product development, commercial partnerships and thought leadership.
David is currently an Adjunct Professor at the Whitman School Of Management at Syracuse University, an Innovation Advisor to the American Hospital Association (AHA) and on the Board Of Directors, Lexington Wellness Holdings for CoachCare product platform. His focus is on corporate entrepreneurship and the adoption of novel therapies through an agile development process.
David holds a Bachelor Of Science from Syracuse University.
Dr. Aditi Joshi MD, MSc is an experienced Emergency Medicine Physician and telehealth expert working on improving healthcare through technology. Through over 6 years of working in Telemedicine on both a startup and academic hospital, she has a keen interest in making technology palatable and effective for both patients, providers, and health care systems. Dr. Joshi is Medical Director of JeffConnect, Thomas Jefferson University Hospital's on-demand telemedicine program and an Assistant Professor in the Department of Emergency Medicine at Sidney Kimmel Medical College at Thomas Jefferson University. She is also co-director of the Digital Health Scholarly Inquiry Track at Sidney Kimmel Medical College, teaching medical students how digital health technologies will influence their careers. She teaches both medical students and residents about telemedicine, digital health and health innovation with both practical and research components, helping to hone how the future physicians think about how technology will change medical practice.
She serves at the Chair-Elect for the Telehealth committee of the American College of Emergency Physicians, a national role to help expand the role of telehealth within the specialty. She regularly contributes articles on issues of merging provider and patient needs to digital health and innovation. She speaks and teaches on strategizing how to bridge the gap between the two worlds.
She completed her residency at Thomas Jefferson University Hospital and has a Masters in International Health Policy from the London School of Economics.
Jim has devoted much of his career to the Life Sciences industry having served in leadership positions in pharmaceutical, medical device, information technology and talent acquisition companies. Initially in pharmaceutical sales at SmithKline (now GlaxoSmithKline plc) and later in 1995 founding Jekeme International, he specialized in identifying and executing business growth strategies for early-stage and middle-market Life Sciences organizations.
In September 2001, he co-founded ParagonRx, a marketing services business focused on the design and implementation of programs for complex drugs, eventually becoming the industry leader in the creation of FDA sanctioned REMS programs. In 2005 Jim joined the startup executive search firm Ashton Tweed, where he created and branded The Life Sciences Talent Bank, connecting executive level industry veterans with clients.
Jim created BioPortUSA in 2007 to assist foreign-based Life Sciences firms establish market entry into the USA. With the resurgence of the global economy in 2017, BioPortUSA identifies a new generation of innovative medical technologies around the world that can have a positive impact on the US healthcare system.
Jim holds a Masters Of Business Administration in International Marketing and a Bachelor Of Science degree in Pharmacology from the University of Western Ontario in London, Canada.
Jack has spent his career practicing law in the Life Sciences and Technology sectors. Beginning in 1992, he served as VP General Counsel for 16 years at Welch Allyn. He then founded Blue Highway, a spin off of Welch Allyn in 2008 where he served as Senior VP, Government & Legal Affairs, managing all legal manners and IP strategy to obtain grants and financing for selected projects.
In October 2012, Jack became affiliated with Barclay Damon to offer broader assistance to new companies in the emerging technology space, addressing legal issues and considerations associated with commercializing technology.
Jack currently is a Professor of Practice, Director of NY Science & Technology Law Center, College of Law at Syracuse University, where he teaches the law and the process relating to the commercialization of technology. He guides students in the Technology Commercialization Law Program, taking on real clients with a product or service and conducts research to assist them with their business plans and go to market strategy.
Since January 2017, he has been the Principal of ICIP Consulting, a research services and consulting company that delivers efficient, timely and cost-effective analysis to help companies make winning decisions on commercialization strategy for early stage technologies. ICIP’s services include intellectual property research, patent landscapes, regulatory considerations, market assessments and competition reports.
Jack holds a Doctor of Jurisprudence in Law from Syracuse University College Of Law and a Bachelor of Science in Political Science/History from Middlebury College.